Propionic Acid for Children with Advanced Kidney Disease

Impact of Propionic Acid on Regulatory T Cell Function in Children With CKD

Recruiting N/A Interventional Study
CKD (Chronic Kidney Disease) Stage 5D
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 20
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
16 (estimated)
Sponsor
Charite University, Berlin, Germany · Other
Who this trial is looking for

This trial is looking for children with severe chronic kidney disease who are on hemodialysis. If you join, you will take a supplement containing propionic acid to help understand its effects on the immune system and gut health.

Are You a Good Fit for This Trial?
Rules you out Chronic gastrointestinal diseasesChronic liver diseasesSubstance abuse

You may be able to join if

  • I weigh more than 30 kg.
  • I have been diagnosed with stage 5 chronic kidney disease.
  • I have been on hemodialysis for more than 3 months.
  • I am in a stable clinical condition.
  • I developed chronic kidney disease during childhood.

You may not be able to join if

  • I have a disease or condition that makes me ineligible.
  • I cannot understand the study or its requirements.
  • I have an acute infection.
  • I have received immunosuppressive therapy in the last 12 weeks.
  • I have taken any pre-, pro-, or postbiotics or antibiotics in the last 4 weeks.
  • I was hospitalized in the last 4 weeks or am planning to be.
  • I have cancer.
  • I am pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Pro-Kids is a multi-center, double-blind, randomized and placebo-controlled intervention study in children with chronic kidney disease. The investigators address the effect of a dietary food supplementation of propionic acid on the immune system and the function of the intestinal barrier in CKD patients treated with hemodialysis.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Body weight: \> 30kg * CKD G5 treated with hemodialysis * Continuous hemodialysis treatment for \> 3 months * Clinical stable condition * Manifestation of CKD within childhood (\<18 years) Exclusion Criteria: * Disease or dysfunctions, which disqualifies the patient * Incapa…
Contacts

Johannes Holle, Dr. med.

004930450516012

johannes-benjamin.holle@charite.de

CONTACT

Nicola Wilck, Dr. med.

004930450516012

nicola.wilck@charite.de

CONTACT